July 1, 2025
The Hidden Cost of Accessing Physical Archives
In pharmaceutical R&D, glass slides represent one of the most valuable yet underleveraged assets. These physical records contain decades of study insights, histological patterns, and high-stakes decisions. But despite their importance, most remain locked in filing cabinets and storage rooms, costing teams both time and opportunity. Without a structured, scalable way to digitise, index, and reuse these assets, organisations risk missing access to critical data, and falling behind in the race for faster, AI-enabled discovery.
Scanning as Infrastructure, Not Just Output
At Patholytix, we don’t treat scanning as a standalone service. We treat it as the starting point for building modern, intelligent research infrastructure. Every slide we scan is barcoded, metadata-enriched, and ready for search, analysis, and collaboration. And because we’ve done this at true enterprise scale - scanning over one million slides for a single large pharma partner - we know how to support both high-throughput digitisation and the rigorous requirements of global pharma teams. We also have end-to-end GLP compliance from Scanning (MHRA) to Patholytix (GLP compliant).
Our scanning operations are built on deep technical and logistical expertise and domain fluency. From our Scanner AI plugin integrations to our proprietary AI-based QC pipelines, we’ve fine-tuned the entire digitisation process for speed and reliability. These custom workflows have delivered up to 21% gains in throughput and significantly reduced the need for costly rescans, lowering operational overhead while accelerating delivery.
Scanning is the moment when data becomes discoverable. It's when decades-old archives can be activated for AI training, or mined for cross-study insights. And importantly, it’s how teams without an existing digital pathology footprint can get started with minimal lift. There’s no need to buy scanners or deploy infrastructure. Just send the slides, and we’ll handle the rest.
What Happens After Scanning Is What Sets Us Apart
Patholytix scanning service produces highest quality digital images which are agnostic and directly integrated into any IMS platform, which means every scanned slide is automatically structured, archived, and made accessible through a secure, GLP-compliant cloud interface. Slides can be filtered, queried, annotated, and shared in real time. Teams can perform remote reviews, engage external consultants, or surface legacy studies for biomarker validation without ever touching a spreadsheet.
More critically, once digitised, slides can be analysed using Patholytix’s and/or third party AI capabilities, from triaging large cohorts for lesion detection to surfacing subtle tissue patterns relevant to early discovery. In translational and exploratory research, this functionality enables faster iteration, deeper insight, and more reproducible decision-making across studies.
Trusted by Pharma, Built for Scale
Unlike generalist platforms that are often adapted from clinical case management systems, Patholytix is built specifically for research pathology, with an ICH study centric workflow. We serve the speed, complexity, and compliance needs of R&D teams, not retrofitted diagnostic workflows. Our infrastructure has been validated across millions of images and is actively deployed with 30 global pharma and CRO organisations. Whether it’s a large-scale archival rescue or fast-turnaround pre-submission scanning, we deliver consistent quality, operational scale, and regulatory alignment.
We offer flexible scanning packages that match your study goals, whether that’s activating decades of archived material, structuring datasets ahead of AI deployment, or enabling in-study collaboration across sites. And because our scanning services connect directly into the Patholytix platform, every digitised slide is immediately ready for action.
Digitise Today, Scale Tomorrow
The most successful teams don’t wait until everything is perfect to go digital. They start with scanning. It’s the lowest-risk, highest-impact on-ramp to modern pathology infrastructure. Even without a full IMS deployment, our scanning customers unlock immediate benefits: searchable slide access, structured metadata, and simplified collaboration with internal or external reviewers.
And when the time comes to scale, Patholytix grows with you, from a single digitised archive to a fully AI-integrated pathology data environment. You can digitise one study, one site, or your entire historical archive. Our infrastructure is designed to keep pace with your ambition.
Don’t Let Another Month Go to Waste
Every delay in digitising your pathology archive represents lost value, missed insights, and unnecessary risk. Physical slides degrade - labels can detach over time and slides are at risk of developing mold or blisters, potentially leading to irreversible loss of valuable legacy material. Study context fades and AI strategies stall before they can even begin. The faster you unlock your archive, the faster you can mine it for answers.
With Patholytix, digitisation is simple, secure, and proven. We’ve done it for the biggest names in pharma. We can do it for you.
Book a consultation today to start scanning with Patholytix Scanning Services.
The Hidden Cost of Accessing Physical Archives
In pharmaceutical R&D, glass slides represent one of the most valuable yet underleveraged assets. These physical records contain decades of study insights, histological patterns, and high-stakes decisions. But despite their importance, most remain locked in filing cabinets and storage rooms, costing teams both time and opportunity. Without a structured, scalable way to digitise, index, and reuse these assets, organisations risk missing access to critical data, and falling behind in the race for faster, AI-enabled discovery.
Scanning as Infrastructure, Not Just Output
At Patholytix, we don’t treat scanning as a standalone service. We treat it as the starting point for building modern, intelligent research infrastructure. Every slide we scan is barcoded, metadata-enriched, and ready for search, analysis, and collaboration. And because we’ve done this at true enterprise scale - scanning over one million slides for a single large pharma partner - we know how to support both high-throughput digitisation and the rigorous requirements of global pharma teams. We also have end-to-end GLP compliance from Scanning (MHRA) to Patholytix (GLP compliant).
Our scanning operations are built on deep technical and logistical expertise and domain fluency. From our Scanner AI plugin integrations to our proprietary AI-based QC pipelines, we’ve fine-tuned the entire digitisation process for speed and reliability. These custom workflows have delivered up to 21% gains in throughput and significantly reduced the need for costly rescans, lowering operational overhead while accelerating delivery.
Scanning is the moment when data becomes discoverable. It's when decades-old archives can be activated for AI training, or mined for cross-study insights. And importantly, it’s how teams without an existing digital pathology footprint can get started with minimal lift. There’s no need to buy scanners or deploy infrastructure. Just send the slides, and we’ll handle the rest.
What Happens After Scanning Is What Sets Us Apart
Patholytix scanning service produces highest quality digital images which are agnostic and directly integrated into any IMS platform, which means every scanned slide is automatically structured, archived, and made accessible through a secure, GLP-compliant cloud interface. Slides can be filtered, queried, annotated, and shared in real time. Teams can perform remote reviews, engage external consultants, or surface legacy studies for biomarker validation without ever touching a spreadsheet.
More critically, once digitised, slides can be analysed using Patholytix’s and/or third party AI capabilities, from triaging large cohorts for lesion detection to surfacing subtle tissue patterns relevant to early discovery. In translational and exploratory research, this functionality enables faster iteration, deeper insight, and more reproducible decision-making across studies.
Trusted by Pharma, Built for Scale
Unlike generalist platforms that are often adapted from clinical case management systems, Patholytix is built specifically for research pathology, with an ICH study centric workflow. We serve the speed, complexity, and compliance needs of R&D teams, not retrofitted diagnostic workflows. Our infrastructure has been validated across millions of images and is actively deployed with 30 global pharma and CRO organisations. Whether it’s a large-scale archival rescue or fast-turnaround pre-submission scanning, we deliver consistent quality, operational scale, and regulatory alignment.
We offer flexible scanning packages that match your study goals, whether that’s activating decades of archived material, structuring datasets ahead of AI deployment, or enabling in-study collaboration across sites. And because our scanning services connect directly into the Patholytix platform, every digitised slide is immediately ready for action.
Digitise Today, Scale Tomorrow
The most successful teams don’t wait until everything is perfect to go digital. They start with scanning. It’s the lowest-risk, highest-impact on-ramp to modern pathology infrastructure. Even without a full IMS deployment, our scanning customers unlock immediate benefits: searchable slide access, structured metadata, and simplified collaboration with internal or external reviewers.
And when the time comes to scale, Patholytix grows with you, from a single digitised archive to a fully AI-integrated pathology data environment. You can digitise one study, one site, or your entire historical archive. Our infrastructure is designed to keep pace with your ambition.
Don’t Let Another Month Go to Waste
Every delay in digitising your pathology archive represents lost value, missed insights, and unnecessary risk. Physical slides degrade - labels can detach over time and slides are at risk of developing mold or blisters, potentially leading to irreversible loss of valuable legacy material. Study context fades and AI strategies stall before they can even begin. The faster you unlock your archive, the faster you can mine it for answers.
With Patholytix, digitisation is simple, secure, and proven. We’ve done it for the biggest names in pharma. We can do it for you.
Book a consultation today to start scanning with Patholytix Scanning Services.
Follow us
Ireland
DCU Alpha Building, Innovation Campus,
11 Old Finglas Rd, Glasnevin, Co. Dublin D11 KXN4
